Navigation Links
ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009
Date:11/13/2009

-------- -------- Income taxes $4,531,026 $2,924,777 Supplemental disclosures of noncash financing activities Issuance of shares in connection with business combinations $918,583 $- -------- ---------- Acquisition of fixed assets under capital leases $- $1,211,158 -------- ----------

NOTES

The functional currency of RPS is US dollars because that is the currency of the primary economic environment in which the company operates. These financial statements are presented in US dollars.

The financial statements are presented in conformity with accounting principles generally accepted in the United States and have been prepared using the same accounting policies as set forth in the financial statements for the year ended December 31, 2008 which will be included in the Company's Annual Report on Form 10-K to be filed with the SEC.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This press release contains "forward-looking statements" that are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as "anticipates," "intends," "plans," "seeks," "believes," "estimates," "expects" and similar references to future periods, or by the inclusion of forecasts or projections. Forward-looking statements are based on the Company's current expectations and assumptions regarding its business, financial condition, the economy and other future conditions. Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict, i
'/>"/>

SOURCE ReSearch Pharmaceutical Services, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
2. New Research Shows Over-use of Asthma Rescue Inhalers Substantially Reduced Through Pharmacist-initiated Physician Intervention
3. New Research Shows Promise in Using Traditional Research Methods to Assess Efficacy of Complementary Therapies
4. Executives Reveal Secrets to Capitalize on New Developments in Pharmaceutical Marketing Research
5. Reportlinker Adds The Global Drug Delivery Market: Research Trends and Market Outlook
6. Sigma-Aldrich Enters Distribution Agreement With Stemgent, Inc. to Offer Lentivirus-Based Gene Delivery Products for Regenerative Medicine and Stem Cell Research
7. Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes
8. Monsanto to Purchase Chesterfield Village Research Center From Pfizer
9. Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration
10. Cantel Medical Corp. to Present at the Sidoti Emerging Growth Research Institutional Investor Forum
11. Codexis Names Fernando Valle Research Fellow
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... -- Hutchison China MediTech Limited ("Chi-Med") ... ("HMP"), its drug R&D subsidiary, successfully achieved the ... of fruquintinib in patients with advanced non-squamous non-small ... .  The top-line results demonstrated that the ... endpoint of progression free survival ("PFS"). ...
(Date:9/3/2015)... With a population of more than 1 ... also its single largest potential market for goods and ... all major world economies in the average rate of ... health expenditures. As an in vitro diagnostics (IVD) market, ... United States, western European countries, and Japan. China represents ...
(Date:9/3/2015)... NEW YORK , Sept. 3, 2015 ... successfully used to save millions of lives across globe. ... the Kingdom of Saudi Arabia . ... raw material suppliers, government agencies and regulatory bodies. The ... been studied from two perspectives: by products and by ...
Breaking Medicine Technology:Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3IVD in China 2IVD in China 3IVD in China 4IVD in China 5IVD in China 6IVD in China 7IVD in China 8IVD in China 9IVD in China 10IVD in China 11IVD in China 12IVD in China 13Saudi Arabia Defibrillators Market: & Advanced Life Support Defibrillators; End Users; Industry Analysis, Size, Volume, Growth, Trends and Forecast 2014 - 2020 2
... 15, 2012 For the 35 million people ... new, fast, effective approach to treatment is now ... light, radiofrequency and ultrasound aesthetic and medical devices, ... newest innovation for the Harmony(XL) multi-application, multi-technology platform, ...
... BARCELONA, Spain, March 15, 2012 Grifols (MCE:GRF, MCE:GRF.P ... largest plasma product manufacturer and a pioneer in the ... to both scientific and social development, has acquired 51% ... the viability of its projects and the future of ...
Cached Medicine Technology:New Nail Fungus Approach Receives FDA Clearance 2Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 2Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 3Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 4Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 5Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 6Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 7Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 8
(Date:9/4/2015)... ... 04, 2015 , ... Georgia Insurance Advisors, a locally owned ... to provide for the family of Grace, a young local girl battling restrictive ... leads to diastolic dysfunction – the inability to adequately move blood through the ...
(Date:9/4/2015)... ... 04, 2015 , ... Keeping mold top of mind is important when considering ... Mold can grow anywhere - on carpet, clothing, food, paper, and even in places ... water in the home is key to preventing mold growth, which if exposed to ...
(Date:9/4/2015)... OR (PRWEB) , ... September 04, 2015 , ... ... markets a line of personal humidifying medical devices, announced its only mission and ... explains Bio-Logic Aqua® Research Founder Sharon Kleyne, body water evaporation is becoming dangerously ...
(Date:9/4/2015)... ... 2015 , ... Lalonde Gordon ran a 44.64 seconds scorcher in the third ... men’s 400 meters final, with an impressive 44.89 seconds at the 2015 North American, ... Rica in August 2015. The 44.64 time is a new NACAC Championship record. ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... ... and medical assistance company today announced that it has entered into a multi-year ... EMED signed an agreement to bridge the link between American healthcare, Jamaican healthcare ...
Breaking Medicine News(10 mins):Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 4Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 5Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 6
... Men with localized prostate cancer treated with a newer ... a quarter (26 percent) fewer late bowel and rectal ... radiation to the bladder and rectum, compared to those ... at the plenary session October 3, 2011, at the ...
... (malignant) brain tumors in children. Although survival rates ... with substantial mortality, and long-term survivors often suffer ... of researchers, led by Cecilia Sderberg-Nauclr and John ... now identified a potential target for a more ...
... women develop functional health challenges earlier than their ... data about the lives of 8,700 older people, ... accelerated rate of reported physical limitations by African ... The finding surfaced as researchers looked ...
... family history of breast cancer, but no genetic link, are not ... with a strong family history of breast cancer, but no genetic ... in their efforts to manage the risk, leading some women to ... has found. The study was led by Dr Louise Keogh ...
... Reporter , SUNDAY, Sept. 25 (HealthDay News) -- The bone ... risk of breast cancer recurrence, should not be used routinely ... new study of breast cancer patients, Zometa (zoledronic acid) did ... the risk of a serious side effect, said study co-author ...
... causes of death and morbidity worldwide, and its economic ... cost of cancer due to premature death and disability, ... billion. An expert report from The Lancet ... the world,s leading cancer specialists, from patient advocates to ...
Cached Medicine News:Health News:IMRT has less harmful rectal side effects than 3D-CRT for prostate cancer patients 2Health News:African-American women develop functional challenges earlier than others 2Health News:African-American women develop functional challenges earlier than others 3Health News:Women with breast cancer with no genetic link, are not fully utilizing breast cancer services 2Health News:Women with breast cancer with no genetic link, are not fully utilizing breast cancer services 3Health News:Bone Drug Fails to Prevent Breast Cancer Recurrence: Study 2Health News:Bone Drug Fails to Prevent Breast Cancer Recurrence: Study 3Health News:Unequal access to cancer care can no longer be tolerated 2Health News:Unequal access to cancer care can no longer be tolerated 3
... Protectant Swabsticks prepare the skin for maximum ... dry, they leave a thin film on ... surface and a barrier for natural body ... a dressing or tape and helps prevent ...
BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness....
BETADINE® Solution Swabsticks are indicated whenever a topical microbicide is applied most conveniently with a swabstick....
... BD Persist contains 70% alcohol and ... unique polymer base, forming a barrier ... a protective environment for the povidone ... most commonly associated with catheter related ...
Medicine Products: